Since passage of the first COVID-19 relief bill in early March, Congress has provided roughly $3.6 billion in supplemental appropriations for the NIH for COVID-19 research and testing.
Congratulations to HICCC members who have received major research grants, earned prestigious honors, been elected to honorary societies, or taken leadership positions in professional organizations.
The Columbia COVID-19 Biobank has been up and running for just three weeks. The idea is to lend immediate support and invaluable resources to investigators working toward a cure for COVID-19.
The Flow Cytometry Shared Resource at the HICCC supports a wide variety of studies related to cancer biology, functional genomics and tumor immunology using the newest techniques.
The High Throughput Screening shared resource is equipped with state-of-the-art instrumentation, robotic automation, and software for running high-throughput screens using assay technologies.
